◀ Back to IL6
IL6 — KLK3
Text-mined interactions from Literome
Lin et al., Clin Cancer Res 2001
(Prostatic Neoplasms) :
Bicalutamide, an antiandrogen, abolished the IL-6 effect and
IL-6 could not
activate the
PSA and murine mammary tumor virus reporters in AR-negative DU-145 and PC3 cells
Mazmanian et al., Nature 2008
(Colitis...) :
Purified
PSA administered to animals is
required to suppress pro-inflammatory
interleukin-17 production by intestinal immune cells and also inhibits in vitro reactions in cell cultures
Bradley et al., Cancer 2009
(Prostatic Neoplasms) :
Secondary endpoints included safety, rate of
PSA decline, objective response, overall survival, and
effects of vorinostat on serum
interleukin-6 (IL-6) levels
Ogata et al., Joint Bone Spine 2012
(Arthritis, Psoriatic) :
Like rheumatoid arthritis ( RA ), the increased production of interleukin (IL)-6 suggests a pathogenic
role of
IL-6 in
PsA
Ogata et al., Arthritis 2012
:
This suggests that the pathogenic
roles of
IL-6 in
PsA and RA are different ... This paper discusses the
role of
IL-6 in
PsA
Tian et al., World J Gastroenterol 2012
:
APS could
increase IL-1a, IL-2,
IL-6 , and TNF-a expression and decrease IL-10 levels